New insights into the mechanisms involved in renal proximal tubular damage induced in vitro by ochratoxin A

Journal of Biochemical and Molecular Toxicology

Volumn 18, Issue 1, 2004, Pages 43-49

  Gennari, Alessandra ^a   Pazos, Patricia ^a   Boveri, Monica ^a   Callaghan, Robert ^a   Casado, Juan ^a   Maurici, Daniela ^a   Corsini, Emanuela ^b   Prieto, Pilar ^a  

^a ECVAM   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

In vitro; LLC PK1; Nephrotoxicity; Ochratoxin A

Indexed keywords

COMPLEMENTARY DNA; MYCOTOXIN; OCHRATOXIN; PROTEIN ZO1;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL MEMBRANE POTENTIAL; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSKELETON; CYTOTOXICITY; DATA ANALYSIS; DNA MICROARRAY; EPITHELIUM CELL; EXPOSURE; GENE EXPRESSION; GIANT CELL; IN VITRO STUDY; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE DAMAGE; MITOCHONDRION; NEPHROTOXICITY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SENSITIVITY ANALYSIS; SWINE;

ANIMALS; APOPTOSIS; CELL SURVIVAL; CYTOSKELETON; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; KIDNEY TUBULES, PROXIMAL; LLC-PK1 CELLS; MITOCHONDRIA; OCHRATOXINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SWINE;

ANIMALIA; SUIDAE;

EID: 1542360668     PISSN: 10956670     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbt.20006     Document Type: Article

References (33)

1. Merwe van deer KJ, Steyn PS, Fourie L, Scott DB, Theron JJ. Ochratoxin A, a toxic metabolite produced by Aspergillus ochraceus Wilh. Nature 1965;205:1112-1113.
2. Speijers GJA, Egmond van HP. Worldwide ochratoxin A levels in food and feeds. In: Creppy EE, Castegnaro M, Dirheimer G, editors. Human Ochratoxicosis and its Pathologies. Les Editions INSERM. Montrouge, France: John Libbey Eurotext; 1993. Vol. 231, pp, 85-100.
3. Kane A, Creppy EE, Roschenthaler R, Dirheimer G. Changes in urinary and renal tubular enzymes caused by subchronic administration of ochratoxin A in rats. Toxicology 1986;42:233-243.
4. Hult K, Plestina R, Habazin-Novak V, Radic B, Ceovic S. Ochratoxin A in human blood and Balkan endemic nephropathy. Arch Toxicol 1982;51:313-321.
5. Bendele AM, Carlton WW, Krogh P, Lillehoj EB. Ochratoxin A carcinogenesis in the (C57BL/65 X C3H)F1 mouse. J Natl Cancer Inst 1985;75:733-742.
6. Kuiper-Goodman T. Risk assessment of ochratoxin A: An update. Food Addit Contam 1996;13(suppl.):53-57.
7. Jung KY, Endou H. Nephrotoxicity assessement by measuring cellular ATP content. II. Intranephron site of ochratoxin A nephrotoxicity. Toxicol Appl Pharmacol 1989;100:383-390.
8. Schwerdt G, Gekle M, Freudinger R, Mildenberger S, Silbernagl S. Apical-to-basolateral transepithelial transport of ochratoxin A by two subtypes of madin-darby canine kidney cells. Biochim. Biophys Acta 1997;1324: 191-199.
9. Gekle M, Sauvant C, Schwerdt G, Silbernagl S. Tubulo-toxic mechanisms of ochratoxin A. Kidney Blood Press Res 1998;21:277-279.
10. Schwerdt G, Freudunger S, Mildenberger S, Silbernagl S, Gekle M. The nephrotoxin ochratoxin A induces apoptosis in cultured human proximal tubule cells. Cell Biol Toxicol 1999;15:405-415.
11. Obrecht-Pglumio S, Dirheimer G. In vitro DNA and dGMP adducts, formation caused by ochratoxin A. Chem-Biol Interact 2000;127:29-44.
12. Maresca M, Mahfoud R, Pfohl-Leszkowicz A, and Fantini J. The mycotoxin ochratoxin A alters intestinal barrier and absorption functions but has no effect on chloride secretion. Toxicol Appl Pharmacol 2001;176:54-63.
13. Aleo MD, Wyatt RD, Schnellmann RG. Mitochondrial dysfunction is an early event in ochratoxin A but not oosporein toxicity to rat renal proximal tubules. Toxicol Appl Pharmacol 1991;107:73-80.
14. Schaaf GJ, Nijmeijer SM, Maas RF, Roestenberg P, de Groene EM, Fink-Gremmels J. The role of oxidative stress in the ochratoxin A-mediated toxicity in proximal tubular cells. Biochim Biophys Acta 2002;1588:149-157.
15. Graber M, Pastoriza-Munoz E. Regulation of cell pH by K+/H+ antiport in renal epithelial cells. Am J Physiol 1993;265:773-783.
16. Gstraunthaler G, Steinmassl D, Pfaller W, Renal cell cultures: A tool for studying tubular function and nephrotoxicity. Toxicol Lett 1990;53:1-7.
17. Tyson CA, Green CE. Cytotoxicity measures: Choice and methods. In: Rauckmann EJ, Padillar GM, editors. The Isolated Hepatocyte, Use in Toxicology and Xenobiotic Biotransformations. Orlando: Academic Press; 1987. pp. 119-158.
18. Gennari A, Cortese E, Boveri M, Casado J, Prieto P. Sensitive endpoints for evaluating cadmium-induced acute toxicity in LLC-PK1 cells. Toxicology 2003;183:211-220.
19. Duff T, Carter S, Feldman G, McEwan G, Pfaller W, Rhodes P, Ryan M, Haewksworth G. Transepithelial resistance and inulin permeability as endpoints in in vitro nephrotoxicity testing. ATLA 2002;30:61-67.
20. Stevenson BR, Heintzelman MB, Anderson JM, Citi S, Mooseker MS. ZO-1 and cingulin: Tight junction proteins with distinct identities and localizations. Am J Physiol 1989;257:621-628.
21. Cappelletti G, Maggioni MG, Carnevali MDC, Bonasoro F, Maci R. Dynamic changes in the state of actin polymerization in human alveolar cells exposed to the oxidant agent paraquat. Eur. J Cell Biol 1996;71:293-302.
22. Scientific Committee for Food. Opinion on aflatoxin, ochratoxin A and patulin, expressed on 23rd September 1994. Reports of the Scientific Committee for Food. 35th series, Luxembourg, 1996. pp 1-8.
23. Powell DW. Barrier function of epithelia. Am J Physiol 1981;241:275-288.
24. Lum H, Roebuck KA. Oxidant stress and endothelial cell dysfunction. Am J Physiol Cell Physiol 2001;280:719-741.
25. Eder S, Benesic A, Freudinger R, Engert J, Schwerdt G, Drumm K, Gekle M. Nephritogenic ochratoxin. A interferes with mitochondrial function and pH homeostasis in immortalized human kidney epithelial cells. Pflugers Arch 2000;440:521-529.
26. Schwerdt G, Freudinger R, Scuster C, Silbernagl S, Gekle M. Inhibition of mitochondria prevents cell death in kidney epithelial cells by intra- and extracellular acidification. Kidney Int 2003;1725-1735.
27. Diaz G, Setzu MD, Zucca A, Isola R, Diana A, Murru R, Sogos V, Gremo F. Subcellular heterogeneity of mitochondrial membrane potential: Relationship with organelle distribution and intercellular contacts in normal, hypoxic and apoptotic cells. J Cell Sci 1999;112:1077-1084.
28. Suzuki T, Furusato M, Takasaki S, Ishikawa E. Giant mitochondria in the epithelial cells of the proximal convoluted tubules of diseased human kidneys. Lab Invest 1975;33:578-590.
29. Mihatsch MJ, Olivieri W, Marbet U, Thiel G, Harder F, Zollinger HU. Giant mitochondria in renal tubular cells and cyclosporin A. Lancet 1981;8230:1162-1163.
30. Karbowski M, Kurono C, Wozniak M, Ostrowski M, Teranishi M, Nishikawa Y, Usukura J, Soji T, Wakabayashi T. Free radical-induced mega-mitochondria formation and apoptosis. Free Radical Biol Med 1999;26:396-409.
31. Huang Q, Dunn RT, Jayadev S, DiSorbo O, Pack FD, Farr SB, Stoll RE, Blanchard KF. Assessment of cisplatin-induced nephrotoxicity by microarray technology. Toxicol Sci 2001;63:196-207.
32. Lee PD, Giudice LC, Conover CA, Powell DR. Insulin-like growth factor binding protein-1: Recent findings and new directions. Proc Soc Exp Biol Med 1997;216:319-357.
33. Bohe J, Ding H, Qing DP, Yoon K, Hirschberg R, Wolfgang GH, Kopple JD. IGF-I binding proteins, IGF-I binding protein mRNA and IGF-I receptor mRNA in rats with acute renal failure given IGF-I. Kidney Int 1998;54:1070-1082.